{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T22:41:36Z","timestamp":1782772896220,"version":"3.54.5"},"reference-count":21,"publisher":"SAGE Publications","license":[{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"},{"start":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T00:00:00Z","timestamp":1750291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Sage Open Medical Case Reports"],"published-print":{"date-parts":[[2025,12]]},"abstract":"<jats:p>Bullous pemphigoid is a common subepidermal autoimmune bullous disease that affects the skin and mucous membranes. It is more prevalent in the elderly, often resulting in significant morbidity and mortality. Bullous pemphigoid is rare in solid organ transplant recipients but presents unique challenges due to their underlying immunosuppression, which increases the risks of infection and adverse drug reactions. Herein, we present the first reported case of dupilumab successfully treating bullous pemphigoid in a liver transplant recipient.<\/jats:p>","DOI":"10.1177\/2050313x251350348","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T06:19:13Z","timestamp":1750313953000},"update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":2,"title":["Dupilumab as a treatment for bullous pemphigoid in a liver transplant recipient: A case report"],"prefix":"10.1177","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-8057-0510","authenticated-orcid":false,"given":"Sarah S.","family":"Rashid","sequence":"first","affiliation":[{"name":"Cumming School of Medicine, University of Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P. R\u00e9gine","family":"Mydlarski","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Cumming School of Medicine, University of Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Jafarian","sequence":"additional","affiliation":[{"name":"Division of Dermatology, Department of Medicine, Cumming School of Medicine, University of Calgary, AB, Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2025,6,19]]},"reference":[{"key":"e_1_3_2_2_2","unstructured":"Baigrie D Nookala V. Bullous pemphigoid. In: StatPearls. StatPearls Publishing 2024 http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK535374\/ (accessed 25 July 2024)."},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.3390\/biom10101432"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1002\/jvc2.444"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.928621"},{"key":"e_1_3_2_6_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1194088"},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1155\/2024\/1171779"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/ajd.13760"},{"issue":"5","key":"e_1_3_2_9_2","first-page":"415","article-title":"Bullous pemphigoid in a renal transplant recipient: a case report and review of the literature","volume":"14","author":"Mohaghegh F","year":"2020","unstructured":"Mohaghegh F, Khalili Tembi RS. Bullous pemphigoid in a renal transplant recipient: a case report and review of the literature. Iran J Kidney Dis 2020; 14(5): 415\u2013417.","journal-title":"Iran J Kidney Dis"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1002\/lt.20930"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1111\/jdv.19548"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40257-018-0401-6"},{"issue":"9","key":"e_1_3_2_13_2","first-page":"532","article-title":"Dupilumab (Dupixent)","volume":"43","author":"D\u2019Ippolito D","year":"2018","unstructured":"D\u2019Ippolito D, Pisano M. Dupilumab (Dupixent). Pharm Ther 2018; 43(9): 532\u2013535.","journal-title":"Pharm Ther"},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1115083"},{"issue":"3","key":"e_1_3_2_15_2","first-page":"251","article-title":"Role of IgE in bullous pemphigoid: a review and rationale for IgE directed therapies","volume":"147","author":"Messingham KN","year":"2012","unstructured":"Messingham KN, Pietras TA, Fairley JA. Role of IgE in bullous pemphigoid: a review and rationale for IgE directed therapies. G Ital Dermatol E Venereol 2012; 147(3): 251\u2013257.","journal-title":"G Ital Dermatol E Venereol"},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1586\/1744666X.2016.1123092"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1001\/jamadermatol.2018.2526"},{"issue":"11","key":"e_1_3_2_18_2","doi-asserted-by":"crossref","DOI":"10.5070\/D32511046147","article-title":"Dupilumab for bullous pemphigoid with intractable pruritus","volume":"25","author":"Seidman JS","year":"2019","unstructured":"Seidman JS, Eichenfield DZ, Orme CM. Dupilumab for bullous pemphigoid with intractable pruritus. Dermatol Online J 2019; 25(11): 13030\/qt25q9w6r9.","journal-title":"Dermatol Online J"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaad.2020.01.089"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.18176\/jiaci.0682"},{"key":"e_1_3_2_21_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11123367"},{"key":"e_1_3_2_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0190-9622(87)70115-7"}],"container-title":["Sage Open Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050313X251350348","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1177\/2050313X251350348","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/2050313X251350348","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:19:55Z","timestamp":1767676795000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/2050313X251350348"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,19]]},"references-count":21,"alternative-id":["10.1177\/2050313X251350348"],"URL":"https:\/\/doi.org\/10.1177\/2050313x251350348","relation":{},"ISSN":["2050-313X","2050-313X"],"issn-type":[{"value":"2050-313X","type":"print"},{"value":"2050-313X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,19]]},"article-number":"2050313X251350348"}}